Washington, D.C. - Direct-to-consumer (DTC) advertising of prescription drugs is growing and is boosting spending on pharmaceuticals, so the Food and Drug Administration (FDA) needs to pick up the pace to remove false or misleading commercials from the air. Those are the main conclusions of a landmark report on DTC advertising from Congress' General Accounting Office ("FDA Oversight of Direct-to-Consumer Advertising Has Limitations," available at www.gao.gov).
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen